Our results have demonstrated arbutin could reverse the expression of the FXR and downstream genes in the cholestasis mice model, suggesting that arbutin could reduce the synthesis as well as increase transport or detoxification of bile acids by regulating the FXR. The gene discussed is NR1H4; the disease is cholestasis.